Skip to Content

RDY 399 (Lansoprazole Delayed Release 30 mg)

Pill with imprint RDY 399 is Pink / Black, Capsule-shape and has been identified as Lansoprazole delayed release 30 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Lansoprazole is used in the treatment of barrett's esophagus; gerd; duodenal ulcer; gastritis/duodenitis; aspiration pneumonia (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 399

Lansoprazole delayed release 30 mg RDY 399
Lansoprazole delayed release 30 mg RDY 399
Lansoprazole delayed release 30 mg RDY 399

Lansoprazole delayed release

RDY 399
30 mg
Pink / Black
Rx and/or OTC
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dr. Reddy’s Laboratories Inc.
Inactive Ingredients:
hydroxypropyl cellulose
low substituted hydroxypropyl cellulose
magnesium carbonate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol
polysorbate 80
propylene glycol
corn starch
raw sugar
titanium dioxide
magnesium silicate
ferrosoferric oxide
ferric oxide red
ferric oxide yellow
sodium lauryl sulfate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0468 Amerisource Health Services
63739-0555 McKesson Packaging Services

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.